Abstract Tu0078: CEPT1 Promotes the Release of Angiogenic Factors in Diabetic Patients

Objectives: CEPT1, choline/ethanolamine phosphotransferase 1, is an important mediator of de novo phospholipogenesis and is essential for endothelial cell (EC) survival. CEPT1 catalyzes the synthesis of phospholipids that activate the transcription factor peroxisome proliferator-activated receptor α (PPARα). We observed that CEPT1 is elevated in the endothelium of hypoxic and diseased human peripheral arterial segments. Therefore, we hypothesized that Cept1 may play an important role in EC activation and function and promote the release of angiogenic factors. Methods: Western blotting and immunostaining of macro arterial structures in the lower extremities of individuals with peripheral arterial disease (PAD) and with or without type 2 diabetes (T2D who underwent amputation (n=3-5). We engineered a Cre -induced conditional, EC-specific Cept1 overexpression model in C57BL/6J mice. ECs were isolated from Cept1 fl/fl Cre - and Cept1 fl/fl Cre + mice (n=3) and used to evaluate CEPT1, PPARα, VEGF2R, p-eNOS, p-Akt, eNOS and Akt expression with Western blot. All experimental conditions were performed in triplicate and analyzed using a student’s t-test. Results: There was significantly higher CEPT1 in the arterial segments of maximally diseased sections of individuals with T2D ( p<0.05 , Fig 1A-B). Similarly, vascular immunostaining demonstrated higher CEPT1, ACOX1, and VEGF2R content in the ECs of the intima of lower extremity macro arterial structures of patients with T2D, relative to non-T2D subjects (Fig 1C-G). In mice, Cept1 fl/fl Cre + mice also demonstrated significantly higher CEPT1, PPARα, and VEGF2R in the ECs of microvascular structures of ischemic hindlimbs ( p<0.05 , Fig 2A-D). Activated p-eNOS and p-Akt were also elevated in ECs of Cept1 fl/fl Cre + mice ( p<0.05 , Fig 2A, E,&F). Conclusion: This study demonstrates that Cept1 is sufficient for inducing EC activation and function in micro and macro arterial structures in the setting of peripheral arterial ischemia. This highlights the importance of phospholipogenesis in EC physiology, post-ischemic angiogenesis, and tissue regeneration. Future studies will help determine whether selective activation of CEPT1 can provide important therapeutic benefits in the context of peripheral ischemia.